Mirum Pharmaceuticals, Inc. MIRM Other Noncash Income (Expense)
Other Noncash Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s other noncash income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s other noncash income (expense)?
- Mirum Pharmaceuticals, Inc. (MIRM) reported other noncash income (expense) of $278K in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s other noncash income (expense) changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s other noncash income (expense) decreased by 21.9% year-over-year, from $356K to $278K.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s other noncash income (expense)?
- Over 3 years (2022 to 2025), Mirum Pharmaceuticals, Inc.'s other noncash income (expense) has grown at a -26.4% compound annual growth rate (CAGR), from $3.51M to $1.4M.
- What does other noncash income (expense) mean?
- This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.